Richard Scott Blackley Sells 100,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 100,000 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at approximately $28,177,845.60. This represents a 7.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oscar Health Trading Down 3.0%

Shares of NYSE:OSCR opened at $24.53 on Wednesday. The company has a 50 day moving average of $15.94 and a 200-day moving average of $15.48. The firm has a market cap of $7.40 billion, a P/E ratio of -41.58, a P/E/G ratio of 1.77 and a beta of 2.34. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $25.58. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s revenue for the quarter was up 52.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.92 EPS. As a group, analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on OSCR. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research note on Tuesday, April 21st. Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and upped their price target for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research note on Thursday, February 12th. Robert W. Baird increased their target price on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Wall Street Zen raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Oscar Health has a consensus rating of “Hold” and an average price target of $18.22.

Institutional Investors Weigh In On Oscar Health

Several hedge funds have recently made changes to their positions in the company. OneDigital Investment Advisors LLC lifted its position in shares of Oscar Health by 0.6% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after acquiring an additional 779 shares in the last quarter. Focus Partners Wealth lifted its position in shares of Oscar Health by 1.4% in the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after acquiring an additional 824 shares in the last quarter. Equitable Holdings Inc. lifted its position in shares of Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after acquiring an additional 850 shares in the last quarter. Captrust Financial Advisors lifted its position in shares of Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after acquiring an additional 895 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its position in shares of Oscar Health by 5.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock valued at $255,000 after acquiring an additional 938 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.